- Cat. No.
- A11260
Pevonedistat (MLN4924)
Synonyms: MLN-4924
NAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
NEDD8-activating enzyme (NAE) inhibitors support research on neddylation and protein turnover. NAE initiates the activation of the ubiquitin-like protein NEDD8 before its transfer through the conjugation pathway. Attachment of NEDD8 to cullins regulates cullin-RING ubiquitin ligases, which participate in the control of protein degradation. Pevonedistat and TAS4464 are NAE inhibitors assigned to this category. The selection also includes a reagent directed at a later step in neddylation, so individual target annotations should guide studies of this pathway.
Synonyms: MLN-4924
NAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
Synonyms: MLN-4924 HCL
NAE inhibitor MLN4924 binds to and inhibits NAE, which may result in the inhibition of tumor cell proliferation and survival.
ZM223 is a non-sulfamide NEDD8 activating enzyme (NAE) inhibitor that inhibits HCT116 colon cancer cells with an IC50 value of 100 nM.
TAS4464 is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.
NAcM-OPT is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor, which potently inhibits the DCN1-UBE2M interaction.
Synonyms: TAS 4464
TAS4464 (hydrochloride) is a highly potent and selective inhibitor of NEDD8 activating enzyme (NAE), with an IC50 of 0.955 nM.
NAE-IN-M22 is a selective and reversible inhibitor of NEDD8 activating enzyme (NAE), exhibiting potency in the micromolar range. This compound demonstrates significant antitumor activity by inhibiting multiple cancer cell lines and inducing apoptosis specifically in A549 cells. Additionally, NAE-IN-M22 has been shown to effectively inhibit tumor growth in vivo, making it a valuable tool for research into cancer biology and therapeutic applications.
NAE-IN-1 is a potent inhibitor of NAE1, targeting the NEDD8-activating enzyme complex. This compound induces apoptosis and effectively triggers cell cycle arrest at the G2/M phase. Additionally, NAE-IN-1 elevates reactive oxygen species (ROS) levels and inhibits cell migration, demonstrating significant anti-proliferative activity. It serves as a valuable tool for research applications focusing on cancer biology and cell cycle regulation.
ZM223 hydrochloride is a potent non-covalent inhibitor of the NEDD8 activating enzyme (NAE). This compound demonstrates significant anticancer activity, making it a valuable tool in cancer research. Its primary mechanism involves the disruption of NEDD8 conjugation processes, which can lead to altered protein stability and function, thereby influencing various cellular pathways. ZM223 hydrochloride is suitable for investigating the roles of NEDD8 modifications in tumor biology and therapeutic responses.
NAE-IN-3 is a potent and selective non-covalent inhibitor of the NEDD8-activating enzyme (NAE), demonstrating an IC50 of 0.8 μM. This compound functions by competitively obstructing the ATP-binding domain of NAE, thereby impeding its activity. With a specific focus on NAE, NAE-IN-3 shows minimal interaction with analogous E1 enzymes such as UAE and SAE. This inhibitor is valuable for research aimed at understanding cancer biology and the role of NEDD8 modifications in oncogenesis.
Out of stock
All 3 sizes